Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell and Indolent B-Cell Lymphomas
Conditions: T-Cell Lymphoma; Indolent B-Cell Lymphoma Interventions: Drug: Duvelisib; Procedure: Peripheral blood draw Sponsors: Washington University School of Medicine; Verastem, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials